Scholarlink

Background <p>Acute respiratory illness (ARI) is one of the most common illnesses globally, affecting all age groups and leading to both upper respiratory tract infections (URTIs) and lower respiratory tract infections (LRTIs). Viral pathogens such as influenza viruses and SARS-CoV-2 are major contributors to upper respiratory tract infections and continue to pose significant clinical and public health challenges.</p> Aim <p>This study aimed to compare the clinical presentation and haematological profiles of adult patients with rRT-PCR-confirmed SARS-CoV-2, Influenza A, Influenza B, and virus-negative URTIs presenting to a tertiary-care hospital in Pune.</p> Materials and methods <p>Nasopharyngeal swab samples collected from 123 adult patients presenting with URTI between March and November 2023 were tested at the ICMR-National Institute of Virology (NIV), Pune, using multiplex real-time reverse transcription polymerase chain reaction (rRT-PCR) assays for detection of SARS-CoV-2, Influenza A/B, and other respiratory viral pathogens. RNA extraction was performed using a Zybio kit, and a multiplex single-tube combo rRT-PCR assay.</p> Results <p>The study examined 123 individuals with upper respiratory tract infections (URTIs), 12 of whom had influenza A, 8 of whom had influenza B, and 6 of whom had SARS-CoV-2. No significant differences were observed in age, anthropometric parameters, vital signs, or comorbidity distribution across groups. Significant intergroup differences were identified in cough, sputum production, vomiting/nausea, and nasal discharge/stuffiness (all <i>p</i> &lt; 0.05). Haematological analysis demonstrated significant variations in total WBC count, lymphocyte, monocyte, and neutrophil percentages. Significant intergroup differences were also observed for NLR (<i>p</i> = 0.0013) and PLR (<i>p</i> = 0.0134).</p> Conclusion <p>This pilot study identified differences in selected symptom profiles and haematological parameters and derived inflammatory indices among patients with SARS-CoV-2, Influenza A, Influenza B, and virus-negative URTIs. These findings may contribute to a better understanding of respiratory infection patterns in clinical settings; however, larger studies are required to validate their diagnostic and clinical significance.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical presentation and detection of SARS-CoV-2, influenza-A/B among patients with upper respiratory tract infections in a tertiary hospital in Pune: a pilot study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月11日

查看全文
  • Priyanka Jali,
  • Varsha Potdar,
  • Anil Pardeshi,
  • Poonam Suryawanshi,
  • Madhura Gandhi,
  • Shrishail Sarawade,
  • Shubhangi Kanitkar,
  • Vikram Vikhe,
  • Madhusudan Barthwal,
  • Sachin Dole,
  • Hanumant Chavan,
  • Ratnakar Parag,
  • Divya Bhattad,
  • Sheetal Jadhav,
  • Veena Vipat,
  • Srikanth Tripathy

摘要

Background

Acute respiratory illness (ARI) is one of the most common illnesses globally, affecting all age groups and leading to both upper respiratory tract infections (URTIs) and lower respiratory tract infections (LRTIs). Viral pathogens such as influenza viruses and SARS-CoV-2 are major contributors to upper respiratory tract infections and continue to pose significant clinical and public health challenges.

Aim

This study aimed to compare the clinical presentation and haematological profiles of adult patients with rRT-PCR-confirmed SARS-CoV-2, Influenza A, Influenza B, and virus-negative URTIs presenting to a tertiary-care hospital in Pune.

Materials and methods

Nasopharyngeal swab samples collected from 123 adult patients presenting with URTI between March and November 2023 were tested at the ICMR-National Institute of Virology (NIV), Pune, using multiplex real-time reverse transcription polymerase chain reaction (rRT-PCR) assays for detection of SARS-CoV-2, Influenza A/B, and other respiratory viral pathogens. RNA extraction was performed using a Zybio kit, and a multiplex single-tube combo rRT-PCR assay.

Results

The study examined 123 individuals with upper respiratory tract infections (URTIs), 12 of whom had influenza A, 8 of whom had influenza B, and 6 of whom had SARS-CoV-2. No significant differences were observed in age, anthropometric parameters, vital signs, or comorbidity distribution across groups. Significant intergroup differences were identified in cough, sputum production, vomiting/nausea, and nasal discharge/stuffiness (all p < 0.05). Haematological analysis demonstrated significant variations in total WBC count, lymphocyte, monocyte, and neutrophil percentages. Significant intergroup differences were also observed for NLR (p = 0.0013) and PLR (p = 0.0134).

Conclusion

This pilot study identified differences in selected symptom profiles and haematological parameters and derived inflammatory indices among patients with SARS-CoV-2, Influenza A, Influenza B, and virus-negative URTIs. These findings may contribute to a better understanding of respiratory infection patterns in clinical settings; however, larger studies are required to validate their diagnostic and clinical significance.